lobbying_activities: 2468110
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2468110 | bad03988-a599-44d5-9516-49137d35fe44 | Q2 | TWENTY-FIRST CENTURY GROUP, INC. | 38687 | NRX PHARMACEUTICALS INC (FORMERLY KNOWN AS NEURORX) | 2020 | second_quarter | MED | Research and treatment related to suicide prevention for veterans and patients with bipolar depression; COVID-19 research and treatment. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2020-07-16T11:59:12.140000-04:00 |